153 related articles for article (PubMed ID: 35896970)
1. SARS-CoV-2 lineage dynamics in England from September to November 2021: high diversity of Delta sub-lineages and increased transmissibility of AY.4.2.
Eales O; Page AJ; de Oliveira Martins L; Wang H; Bodinier B; Haw D; Jonnerby J; Atchison C; ; Ashby D; Barclay W; Taylor G; Cooke G; Ward H; Darzi A; Riley S; Chadeau-Hyam M; Donnelly CA; Elliott P
BMC Infect Dis; 2022 Jul; 22(1):647. PubMed ID: 35896970
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 infection and vaccine effectiveness in England (REACT-1): a series of cross-sectional random community surveys.
Chadeau-Hyam M; Wang H; Eales O; Haw D; Bodinier B; Whitaker M; Walters CE; Ainslie KEC; Atchison C; Fronterre C; Diggle PJ; Page AJ; Trotter AJ; Ashby D; Barclay W; Taylor G; Cooke G; Ward H; Darzi A; Riley S; Donnelly CA; Elliott P;
Lancet Respir Med; 2022 Apr; 10(4):355-366. PubMed ID: 35085490
[TBL] [Abstract][Full Text] [Related]
3. The dynamics of circulating SARS-CoV-2 lineages in Bogor and surrounding areas reflect variant shifting during the first and second waves of COVID-19 in Indonesia.
Prasetyoputri A; Dharmayanthi AB; Iryanto SB; Andriani A; Nuryana I; Wardiana A; Ridwanuloh AM; Swasthikawati S; Hariyatun H; Nugroho HA; Idris I; Indriawati I; Noviana Z; Oktavia L; Yuliawati Y; Masrukhin M; Hasrianda EF; Sukmarini L; Fahrurrozi F; Yanthi ND; Fathurahman AT; Wulandari AS; Setiawan R; Rizal S; Fathoni A; Kusharyoto W; Lisdiyanti P; Ningrum RA; Saputra S
PeerJ; 2022; 10():e13132. PubMed ID: 35341058
[TBL] [Abstract][Full Text] [Related]
4. The use of representative community samples to assess SARS-CoV-2 lineage competition: Alpha outcompetes Beta and wild-type in England from January to March 2021.
Eales O; Page AJ; Tang SN; Walters CE; Wang H; Haw D; Trotter AJ; Le Viet T; Foster-Nyarko E; Prosolek S; Atchison C; Ashby D; Cooke G; Barclay W; Donnelly CA; O'Grady J; Volz E; The Covid-Genomics Uk Cog-Uk Consortium ; Darzi A; Ward H; Elliott P; Riley S
Microb Genom; 2023 Feb; 9(2):. PubMed ID: 36745545
[TBL] [Abstract][Full Text] [Related]
5. Spatial growth rate of emerging SARS-CoV-2 lineages in England, September 2020-December 2021.
Smallman-Raynor MR; Cliff AD;
Epidemiol Infect; 2022 Jul; 150():e145. PubMed ID: 35855577
[TBL] [Abstract][Full Text] [Related]
6. Early introduction, dispersal and evolution of Delta SARS-CoV-2 in Southern Brazil, late predominance of AY.99.2 and AY.101 related lineages.
Gularte JS; da Silva MS; Mosena ACS; Demoliner M; Hansen AW; Filippi M; Pereira VMAG; Heldt FH; Weber MN; de Almeida PR; Hoffmann AT; Valim ARM; Possuelo LG; Fleck JD; Spilki FR
Virus Res; 2022 Apr; 311():198702. PubMed ID: 35104582
[TBL] [Abstract][Full Text] [Related]
7. COVID-19 vaccine effectiveness against symptomatic SARS-CoV-2 infection and severe COVID-19 outcomes from Delta AY.4.2: Cohort and test-negative study of 5.4 million individuals in Scotland.
Kerr S; Vasileiou E; Robertson C; Sheikh A
J Glob Health; 2022 Jul; 12():05025. PubMed ID: 35802764
[TBL] [Abstract][Full Text] [Related]
8. Early Emergence and Dispersal of Delta SARS-CoV-2 Lineage AY.99.2 in Brazil.
Romano CM; de Oliveira CM; da Silva LS; Levi JE
Front Med (Lausanne); 2022; 9():930380. PubMed ID: 35783651
[TBL] [Abstract][Full Text] [Related]
9. Dominance of Three Sublineages of the SARS-CoV-2 Delta Variant in Mexico.
Taboada B; Zárate S; García-López R; Muñoz-Medina JE; Sanchez-Flores A; Herrera-Estrella A; Boukadida C; Gómez-Gil B; Selem Mojica N; Rosales-Rivera M; Salas-Lais AG; Gutiérrez-Ríos RM; Loza A; Rivera-Gutierrez X; Vazquez-Perez JA; Matías-Florentino M; Pérez-García M; Ávila-Ríos S; Hurtado JM; Herrera-Nájera CI; Núñez-Contreras JJ; Sarquiz-Martínez B; García-Arias VE; Santiago-Mauricio MG; Martínez-Miguel B; Enciso-Ibarra J; Cháidez-Quiróz C; Iša P; Wong-Chew RM; Jiménez-Corona ME; López S; Arias CF
Viruses; 2022 May; 14(6):. PubMed ID: 35746637
[TBL] [Abstract][Full Text] [Related]
10. Molecular Epidemiology of the Norwegian SARS-CoV-2 Delta Lineage AY.63.
Moen LV; Vollan HS; Bråte J; Hungnes O; Bragstad K
Viruses; 2022 Dec; 14(12):. PubMed ID: 36560738
[TBL] [Abstract][Full Text] [Related]
11. Neutralisation of the SARS-CoV-2 Delta variant sub-lineages AY.4.2 and B.1.617.2 with the mutation E484K by Comirnaty (BNT162b2 mRNA) vaccine-elicited sera, Denmark, 1 to 26 November 2021.
Lassaunière R; Polacek C; Fonager J; Bennedbæk M; Boding L; Rasmussen M; Fomsgaard A
Euro Surveill; 2021 Dec; 26(49):. PubMed ID: 34886943
[TBL] [Abstract][Full Text] [Related]
12. Molecular Epidemiology of AY.28 and AY.104 Delta Sub-lineages in Sri Lanka.
Ranasinghe D; Jayathilaka D; Jeewandara C; Gunasinghe D; Ariyaratne D; Jayadas TTP; Kuruppu H; Wijesinghe A; Bary FF; Madhusanka D; Pushpakumara PD; Guruge D; Wijayamuni R; Ogg GS; Malavige GN
Front Public Health; 2022; 10():873633. PubMed ID: 35801250
[TBL] [Abstract][Full Text] [Related]
13. Emergence and Spread of the SARS-CoV-2 Variant of Concern Delta across Different Brazilian Regions.
Arantes I; Gomes Naveca F; Gräf T; ; Miyajima F; Faoro H; Luz Wallau G; Delatorre E; Reis Appolinario L; Cavalcante Pereira E; Venas TMM; Sampaio Rocha A; Serrano Lopes R; Mendonça Siqueira M; Bello G; Cristina Resende P
Microbiol Spectr; 2022 Oct; 10(5):e0264121. PubMed ID: 36000897
[TBL] [Abstract][Full Text] [Related]
14. One health genomic surveillance and response to a university-based outbreak of the SARS-CoV-2 Delta AY.25 lineage, Arizona, 2021.
Yaglom HD; Maurer M; Collins B; Hojnacki J; Monroy-Nieto J; Bowers JR; Packard S; Erickson DE; Barrand ZA; Simmons KM; Brock BN; Lim ES; Smith S; Hepp CM; Engelthaler DM
PLoS One; 2022; 17(10):e0272830. PubMed ID: 36315517
[TBL] [Abstract][Full Text] [Related]
15. A prospective, randomized, single-blinded, crossover trial to investigate the effect of a wearable device in addition to a daily symptom diary for the Remote Early Detection of SARS-CoV-2 infections (COVID-RED): a structured summary of a study protocol for a randomized controlled trial.
Brakenhoff TB; Franks B; Goodale BM; van de Wijgert J; Montes S; Veen D; Fredslund EK; Rispens T; Risch L; Dowling AV; Folarin AA; Bruijning P; Dobson R; Heikamp T; Klaver P; Cronin M; Grobbee DE;
Trials; 2021 Oct; 22(1):694. PubMed ID: 34635140
[TBL] [Abstract][Full Text] [Related]
16. Protection against symptomatic infection with delta (B.1.617.2) and omicron (B.1.1.529) BA.1 and BA.2 SARS-CoV-2 variants after previous infection and vaccination in adolescents in England, August, 2021-March, 2022: a national, observational, test-negative, case-control study.
Powell AA; Kirsebom F; Stowe J; Ramsay ME; Lopez-Bernal J; Andrews N; Ladhani SN
Lancet Infect Dis; 2023 Apr; 23(4):435-444. PubMed ID: 36436536
[TBL] [Abstract][Full Text] [Related]
17. SARS-CoV-2 genomic surveillance in Malaysia: displacement of B.1.617.2 with AY lineages as the dominant Delta variants and the introduction of Omicron during the fourth epidemic wave.
Azami NAM; Perera D; Thayan R; AbuBakar S; Sam IC; Salleh MZ; Isa MNM; Ab Mutalib NS; Aik WK; Suppiah J; Tan KK; Chan YF; Teh LK; Azzam G; Rasheed ZBM; Chan JCJ; Kamel KA; Tan JY; Khalilur Rahman O; Lim WF; Johari NA; Ishak M; Yunos RIM; Anasir MI; Wong JE; Fu JYL; Noorizhab MNF; Sapian IS; Mokhtar MFM; Md Shahri NAA; Ghafar K; Yusuf SNHM; Noor YM; Jamal R;
Int J Infect Dis; 2022 Dec; 125():216-226. PubMed ID: 36336246
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021.
Cohen C; Kleynhans J; von Gottberg A; McMorrow ML; Wolter N; Bhiman JN; Moyes J; du Plessis M; Carrim M; Buys A; Martinson NA; Kahn K; Tollman S; Lebina L; Wafawanaka F; du Toit J; Xavier Gómez-Olivé F; Dawood FS; Mkhencele T; Sun K; Viboud C; ; Tempia S
medRxiv; 2021 Dec; ():. PubMed ID: 34909794
[TBL] [Abstract][Full Text] [Related]
19. Detection and Molecular Characterization of the SARS-CoV-2 Delta Variant and the Specific Immune Response in Companion Animals in Switzerland.
Kuhlmeier E; Chan T; Agüí CV; Willi B; Wolfensberger A; Beisel C; Topolsky I; Beerenwinkel N; Stadler T; Swiss Sars-CoV-Sequencing Consortium ; Jones S; Tyson G; Hosie MJ; Reitt K; Hüttl J; Meli ML; Hofmann-Lehmann R
Viruses; 2023 Jan; 15(1):. PubMed ID: 36680285
[TBL] [Abstract][Full Text] [Related]
20. The Delta variant wave in Tunisia: Genetic diversity, spatio-temporal distribution and evidence of the spread of a divergent AY.122 sub-lineage.
Haddad-Boubaker S; Arbi M; Souiai O; Chouikha A; Fares W; Edington K; Sims S; Camma C; Lorusso A; Diagne MM; Diallo A; Boubaker IBB; Ferjani S; Mastouri M; Mhalla S; Karray H; Gargouri S; Bahri O; Trabelsi A; Kallala O; Hannachi N; Chaabouni Y; Smaoui H; Meftah K; Bouhalila SB; Foughali S; Zribi M; Lamari A; Touzi H; Safer M; Alaya NB; Kahla AB; Gdoura M; Triki H
Front Public Health; 2022; 10():990832. PubMed ID: 36684874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
